DNALabs Canada

DNALabs Canada

Growth Stage

Genetic Testing Solutions

Genetic Testing Solutions

Overview

Raised to Date: Raised: $99,693

Total Commitments ($USD)

Platform

Dalmore Group

Start Date

10/20/2022

Close Date

Not Provided

Min. Goal
$225
Max. Goal
$9,999,999
Min. Investment

$225

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$9.00

Pre-Money Valuation

$76,941,684

Rolling Commitments ($USD)

Status
Funded
Reporting Date

10/30/2023

% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$268

# of Investors

21

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Logos provided by Clearbit
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Medium

Capital Intensity

Low

Location

Toronto, Ontario

Business Type

Growth

Company Website

DNALabs Canada is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. The company is focused on developing safe and useful genetic testing products across Canada and the US. The innovative, useful, and affordable DNA testing products of DNALabs Canada are well-established and available through hospitals, medical clinics, pharmacies, and an online shop. DNALabs Canada has delivered over 6,000 tests to date with 99.97% accuracy and received more than 100,000 recommendations. Moni Lustig founded DNALabs Canada in 2016. The current crowdfunding campaign has a maximum target of $9.99 million. The campaign proceeds will be used for marketing, development of the Health Locker app, R&D on new projects, hiring, and working capital.

Balance Sheet

Cash and Cash Equivalents

$347,527

Accounts and Notes Receivable

$50,535
Total Assets

$529,300

Accounts Payable & Accrued Liabilities

$192,455

Long Term Debt

$38,386

Total Liabilities

$265,203

Total Stockholders' Equity

$-1,044,059
Total Liabilities and Equity

$529,300

Statement of Comprehensive Income Information

Total Revenues

$441,716

Costs & Expenses Applicable to Rev

$205,863

Depreciation and Amortization

$0
Net Income

$-169,041

Earnings Per Share - Basic

$-25.59

Earnings Per Share - Diluted

$-25.59
Auditor: Daszkal Bolton LLC
Financials as of: 10/20/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
DNALabs Canada on Dalmore Group 2022
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $76,941,684
Price per Share: $9.00

Follow company

Follow DNALabs Canada on Dalmore Group 2022
View on Dalmore Group (Closed)
Deal Analytics
Company Ratings
Deal Considerations

Buy DNALabs Canada's Deal Report

Warning: according to the close date for this deal, DNALabs Canada may no longer be accepting investments.

DNALabs Canada Deal Report

Get KingsCrowd’s comprehensive report on DNALabs Canada including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether DNALabs Canada is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the DNALabs Canada deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge